Placental insufficiency decreases pancreatic vascularity and disrupts hepatocyte growth factor signaling in the pancreatic islet endothelial cell in fetal sheep

Diabetes

Volumn 64, Issue 2, 2015, Pages 555-564

  Rozance, Paul J ^a,b   Anderson, Miranda ^c   Martinez, Marina ^c   Fahy, Anna ^c   Macko, Antoni R ^c   Kailey, Jenai ^a,b   Seedorf, Gregory J ^a,d   Abman, Steven H ^a,d   Hay, William W ^a,d   Limesand, Sean W ^c  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b Perinatal Research Center   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; SCATTER FACTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS WEIGHT; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HISTOLOGY; INSULIN RELEASE; INTRAUTERINE GROWTH RETARDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVINE MODEL; PANCREAS BLOOD FLOW; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PARACRINE SIGNALING; PLACENTA INSUFFICIENCY; PLACENTA WEIGHT; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; EMBRYOLOGY; PANCREAS; PHYSIOLOGY; SHEEP; VASCULARIZATION; VETERINARY;

ANIMALS; ENDOTHELIAL CELLS; FEMALE; FETAL GROWTH RETARDATION; FETUS; HEPATOCYTE GROWTH FACTOR; ISLETS OF LANGERHANS; PANCREAS; PLACENTAL INSUFFICIENCY; PREGNANCY; SHEEP; SIGNAL TRANSDUCTION;

EID: 84921903935     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0462     Document Type: Article

References (43)

1. Peiris H, Bonder CS, Coates PT, Keating DJ, Jessup CF. The β-cell/EC axis: how do islet cells talk to each other? Diabetes 2014;63:3-11
2. Nicolini U, Hubinont C, Santolaya J, Fisk NM, Rodeck CH. Effects of fetal intravenous glucose challenge in normal and growth retarded fetuses. Horm Metab Res 1990;22:426-430
3. Van Assche FA, De Prins F, Aerts L, Verjans M. The endocrine pancreas in small-for-dates infants. Br J Obstet Gynaecol 1977;84:751-753
4. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001;60:5-20
5. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor- A is essential for islet vascularization, revascularization, and function. Diabetes 2006;55:2974-2985
6. Garcia-Ocaña A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 2000;275:1226-1232
7. Mellado-Gil J, Rosa TC, Demirci C, et al. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Diabetes 2011;60:525-536
8. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell 2006;10:397-405
9. Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO. Islet endothelial cells and pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology 2006;147:2315-2324
10. Konstantinova I, Lammert E. Microvascular development: learning from pancreatic islets. BioEssays 2004;26:1069-1075
11. Lammert E, Gu G, McLaughlin M, et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003;13:1070-1074
12. Johansson A, Lau J, Sandberg M, Borg LA, Magnusson PU, Carlsson PO. Endothelial cell signalling supports pancreatic beta cell function in the rat. Diabetologia 2009;52:2385-2394
13. Johansson M, Andersson A, Carlsson PO, Jansson L. Perinatal development of the pancreatic islet microvasculature in rats. J Anat 2006;208:191-196
14. Dai C, Li Y, Yang J, Liu Y. Hepatocyte growth factor preserves beta cell mass and mitigates hyperglycemia in streptozotocin-induced diabetic mice. J Biol Chem 2003;278:27080-27087
15. García-Ocaña A, Vasavada RC, Cebrian A, et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 2001;50:2752-2762
16. Dai C, Huh CG, Thorgeirsson SS, Liu Y. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol 2005;167:429-436
17. Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocaña A. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes 2005;54:2090-2102
18. Weber LM, Hayda KN, Anseth KS. Cell-matrix interactions improve beta-cell survival and insulin secretion in three-dimensional culture. Tissue Eng Part A 2008;14:1959-1968
19. Nakata M, Yada T. Endocrinology: nitric oxide-mediated insulin secretion in response to citrulline in islet beta-cells. Pancreas 2003;27:209-213
20. Rozance PJ, Seedorf GJ, Brown A, et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011;301:L860-L871
21. Duvillié B, Currie C, Chrones T, et al. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin. Endocrinology 2002;143:1530-1537
22. Vasir B, Aiello LP, Yoon KH, Quickel RR, Bonner-Weir S, Weir GC. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 1998;47:1894-1903
23. Kamba T, Tam BY, Hashizume H, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006;290:H560-H576
24. Reinert RB, Brissova M, Shostak A, et al. Vascular endothelial growth factora and islet vascularization are necessary in developing, but not adult, pancreatic islets. Diabetes 2013;62:4154-4164
25. Ham JN, Crutchlow MF, Desai BM, Simmons RA, Stoffers DA. Exendin-4 normalizes islet vascularity in intrauterine growth restricted rats: potential role of VEGF. Pediatr Res 2009;66:42-46
26. Boujendar S, Arany E, Hill D, Remacle C, Reusens B. Taurine supplementation of a low protein diet fed to rat dams normalizes the vascularization of the fetal endocrine pancreas. J Nutr 2003;133:2820-2825
27. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001;50:2279-2286
28. Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 1991;40(Suppl. 2):115-120
29. Petry CJ, Dorling MW, Pawlak DB, Ozanne SE, Hales CN. Diabetes in old male offspring of rat dams fed a reduced protein diet. Int J Exp Diabetes Res 2001;2:139-143
30. Snoeck A, Remacle C, Reusens B, Hoet JJ. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 1990;57:107-118
31. Limesand SW, Jensen J, Hutton JC, Hay WW Jr. Diminished beta-cell replication contributes to reduced beta-cell mass in fetal sheep with intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol 2005;288:R1297-R1305
32. Limesand SW, Rozance PJ, Macko AR, Anderson MJ, Kelly AC, Hay WW Jr. Reductions in insulin concentrations and β-cell mass precede growth restriction in sheep fetuses with placental insufficiency. Am J Physiol Endocrinol Metab 2013;304:E516-E523
33. Limesand SW, Rozance PJ, Zerbe GO, Hutton JC, Hay WW Jr. Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction. Endocrinology 2006;147:1488-1497
34. Macko AR, Yates DT, Chen X, et al. Elevated plasma norepinephrine inhibits insulin secretion, but adrenergic blockade reveals enhanced β-cell responsiveness in an ovine model of placental insufficiency at 0.7 of gestation. J Dev Orig Health Dis 2013;4:402-410
35. Cole L, Anderson M, Antin PB, Limesand SW. One process for pancreatic beta-cell coalescence into islets involves an epithelial-mesenchymal transition. J Endocrinol 2009;203:19-31
36. Chen X, Green AS, Macko AR, Yates DT, Kelly AC, Limesand SW. Enhanced insulin secretion responsiveness and islet adrenergic desensitization after chronic norepinephrine suppression is discontinued in fetal sheep. Am J Physiol Endocrinol Metab 2014;306:E58-E64
37. Gadhia MM, Maliszewski AM, O'Meara MC, et al. Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase β-cell mass in fetal sheep. Am J Physiol Endocrinol Metab 2013;304:E352-E362
38. Leos RA, Anderson MJ, Chen X, Pugmire J, Anderson KA, Limesand SW. Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction. Am J Physiol Endocrinol Metab 2010;298:E770-E778
39. Rozance PJ, Limesand SW, Zerbe GO, Hay WW Jr. Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic betacells. Am J Physiol Endocrinol Metab 2007;292:E1256-E1264
40. Le Couter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890-893
41. Moriyama T, Kataoka H, Hamasuna R, et al. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 1998;249:73-77
42. Van Belle E, Witzenbichler B, Chen D, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998;97:381-390
43. Wojta J, Kaun C, Breuss JM, et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab Invest 1999;79:427-438